Table 5.
Total UCDAI score (patient including withdrawn with completed UCDAI score).
| IBD98-M 0.8 g/day (N = 12) | IBD98-M 1.2 g/day (N = 14) | Placebo (N = 14) | |
|---|---|---|---|
| UCDAI at Baseline | |||
| n | 12 | 14 | 14 |
| Median (range) | 5.00 (4–10) | 5.50 (4–10) | 5.00 (4–8) |
| UCDAI at Visit 6 | |||
| n | 12 | 14 | 14 |
| Median | 4.00 (1–9) | 4.50 (0–11) | 5.00 (0–10) |
| UCDAI at Visit 6 – Baseline | |||
| n | 12 | 14 | 14 |
| Median | −1.00 (−4–3) | −1.00 (−5–1) | −1.00 (−4–6) |
| p value * | 0.837 | 0.335 |
*p value comparing treatment groups (IBD98 vs. placebo) using ANCOVA. Since the population was small, and the distribution was not normal, the median was used to show the changes in the endoscopic subscore.